These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3293660)

  • 1. Modifications of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet.
    Morgan LM; Hampton SM; Tredger JA; Cramb R; Marks V
    Br J Nutr; 1988 May; 59(3):373-80. PubMed ID: 3293660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dietary modification and hyperglycaemia on gastric emptying and gastric inhibitory polypeptide (GIP) secretion.
    Morgan LM; Tredger JA; Hampton SM; French AP; Peake JC; Marks V
    Br J Nutr; 1988 Jul; 60(1):29-37. PubMed ID: 3408703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pretreatment with a high fat diet on the gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats.
    Hampton SM; Kwasowski P; Tan K; Morgan LM; Marks V
    Diabetologia; 1983 Apr; 24(4):278-81. PubMed ID: 6345248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).
    Stöckmann F; Ebert R; Creutzfeldt W
    Diabetes; 1984 Jun; 33(6):580-5. PubMed ID: 6373462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R; Frerichs H; Creutzfeldt W
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity.
    Heptulla RA; Tamborlane WV; Cavaghan M; Bronson M; Limb C; Ma YZ; Sherwin RS; Caprio S
    Pediatr Res; 2000 May; 47(5):628-33. PubMed ID: 10813588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of energy source and feeding level on the hormones of the entero-insular axis and plasma glucose in the growing pig.
    Ponter AA; Salter DN; Morgan LM; Flatt PR
    Br J Nutr; 1991 Sep; 66(2):187-97. PubMed ID: 1760441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).
    Meier JJ; Gallwitz B; Siepmann N; Holst JJ; Deacon CF; Schmidt WE; Nauck MA
    Regul Pept; 2003 May; 113(1-3):95-100. PubMed ID: 12686467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral galactose on GIP and insulin secretion in man.
    Morgan LM; Wright JW; Marks V
    Diabetologia; 1979 Apr; 16(4):235-9. PubMed ID: 428694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effect of fat on insulin secretion.
    Collier GR; Greenberg GR; Wolever TM; Jenkins DJ
    J Clin Endocrinol Metab; 1988 Feb; 66(2):323-6. PubMed ID: 3276722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
    Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
    Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented gastric inhibitory polypeptide and insulin responses to a meal after an increase in carbohydrate (sucrose) intake.
    Mazzaferri EL; Starich GH; St Jeor ST
    J Clin Endocrinol Metab; 1984 Apr; 58(4):640-5. PubMed ID: 6365944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and C-peptide levels after oral and intravenous glucose. Contribution of enteroinsular axis to insulin secretion.
    Hampton SM; Morgan LM; Tredger JA; Cramb R; Marks V
    Diabetes; 1986 May; 35(5):612-6. PubMed ID: 3514335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparity between glucose-dependent insulinotropic polypeptide and insulin responses in obese man.
    Sarson DL; Kopelman PG; Besterman HS; Pilkington TR; Bloom SR
    Diabetologia; 1983 Nov; 25(5):386-91. PubMed ID: 6360777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.